Subretinal implant partially restores vision in AMD patients
Age-related macular degeneration (AMD) causes progressive vision loss in many elderly people, and no treatment is available for the so-called atrophic form of the disease. A neurostimulation system called Prima, including a subretinal implant, could change all that. The results of a clinical trial involving Inserm, Sorbonne University and CNRS - via the Institut de la vision -, the Hôpital Fondation Adolphe de Rothschild and the Hôpital national des 15-20 show that it partially restored sight in over 80% of participants with AMD, who recovered their ability to read letters, numbers and words. The results are published in the New England journal of medicine.
Age-related macular ...